STAT Plus: FDA pauses Regenxbio gene therapy trial again due to safety concerns
Five patients were found to have small masses on their spines. Regenxbio has faced previous safety concerns with its gene therapies.
Open original source
Five patients were found to have small masses on their spines. Regenxbio has faced previous safety concerns with its gene therapies.
Open original sourceComments stay attached to this story.
Start a connected post from this article without changing the original story.
Creators building their communities through the SpiderTaz Creator Program.
No comments yet.